NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
9.32
+0.19 (2.08%)
Aug 13, 2025, 4:00 PM - Market closed
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $308.32 million as of August 14, 2025. Its market cap has increased by 40.10% in one year.
Market Cap
308.32M
Enterprise Value
317.70M
1-Year Change
40.10%
Ranking
Category
Stock Price
$9.32
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has decreased from $393.28M to $308.32M, a decrease of -21.60%. That is a compound annual growth rate of -5.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 308.32M | -7.69% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |